Attention-deficit/hyperactivity disorder and disruptive behavior disorders in adolescence related to levels of platelet MAO-B and polymorphisms in two candidate genes by Malmberg, Kerstin
 
Department of Children’s and Women’s Health  
Child and Adolescent Psychiatric Unit 
Karolinska Institutet, Stockholm, Sweden 
 
Attention-Deficit/Hyperactivity 
Disorder and Disruptive Behavior 
Disorders in adolescence related 
to levels of platelet MAO-B 
and polymorphisms in two 
candidate genes 
Kerstin Malmberg 
 
Stockholm 2011 
 All previously published papers were reproduced with permission from the publisher. 
 
Published by Karolinska Institutet. Printed by [name of printer] 
 
© Kerstin Malmberg, 2011 
ISBN 978-91-7457-460-9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my mother and father 
 
 ABSTRACT 
Background: Attention-Deficit/Hyperactivity Disorder (ADHD) and Disruptive 
Behavior Disorders (DBD) (including Oppositional Defiant Disorder (ODD) and 
Conduct Disorder (CD)), are common developmental and behaviour diagnoses among 
adolescents. Several of their symptoms, have been linked to genotypes (e.g. 
monoamine oxidase A Variable Number of Tandem Repeats (MAO-A VNTR) and the 
5–HydroxyTryptamine Transporter gene-Linked Polymorphic Region (5-HTT LPR)) 
as well as to platelet Monoamine oxidase B (MAO-B) activity. 
Aim: 1) To study the symptoms of ADHD and DBD phenotypes in adolescents and 
their association with MAO-B activity in platelets, MAO-A VNTR and 5-HTT LPR 
genotypes separately and in combination. 2) To describe the complexity of the 
phenotypes in relation to various psychiatric problems and risk behaviours. 3) To 
investigate psychiatric and behavioural symptoms separately, rather than the complete 
diagnosis and their association with individual and combinations of candidate genes. 
Methods: A population-based sample of twins including 177 girls and 135 boys was 
interviewed using the Swedish version of Kiddie Schedule for Affective Disorders and 
Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL). 
Diagnoses of ADHD and DBD were compiled based on the Diagnostic and Statistical 
Manual of Mental Disorders Text Revision (DSM-IV-TR) diagnostic criteria. Blood 
was drawn from the subjects and analysed for platelet MAO-B activity and 
polymorphisms in the MAO-A VNTR and 5-HTT LPR genotypes.  
Results: 1) For both boys and girls the heterozygote 5-HTT LPR genotype was found 
to be related to symptoms of CD. Girls exhibited an association between low platelet 
MAO-B activity and symptoms of ODD and DBD. An association was found in boys 
between the short MAO-A VNTR allele and symptoms of DBD, as well as between 
ADHD-like problems and the presence of a short 5-HTT LPR or short MAO-A VNTR 
allele, in combination with high levels of platelet MAO-B enzyme activity. 2) In girls, 
subthreshold diagnoses of ADHD and DBD coexisted with symptoms of depression, 
mania, panic attacks, phobias, anorexia nervosa, motor tics and post-traumatic stress 
disorder (PTSD) while in boys with symptoms of depression and PTSD. In both boys 
and girls, smoking and high alcohol consumption contributed to a high risk of having 
these phenotypes. 3) The combination of low MAO-B activity in platelets and 
polymorphism in the 5-HTT LPR genotype was associated with several psychiatric 
symptoms. 
Conclusions: Polymorphisms in the 5-HTT LPR and MAO-A VNTR as well as 
MAO-B activity platelet separately and in combination are related to both ADHD and 
DBD. The complexity of the ADHD and DBD phenotypes was shown by the 
association with several psychiatric and behavioural problems. A broad clinical 
assessment is needed for adolescents with such preliminary diagnoses and the 
serotonergic system should be further investigated when studying genetic influences on 
the complex ADHD and DBD phenotypes. 
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1 PROLOGUE 
 
I graduated from medical school in 1984 and when I was working to get a medical 
licence, I came in contact with child and adolescent psychiatry, which aroused my 
interest in this area. After obtaining my medical licence in 1988, I began my education 
as a child and adolescent psychiatrist and became a specialist 1993. Early in my 
training I developed an interest in helping children and adolescents with 
neuropsychiatric disorders and I have an extensive clinical experience of assessment 
and treatment of children in this area. During my clinical work I encountered many 
children with neuropsychiatric disorders. To learn more about the cause of these 
disabilities, I began to study scientific reports, which made me even more interested 
and inspired me to start my own project. This thesis has given me the opportunity to 
explore issue concerning children with neuropsychiatric symptoms and behavioural 
problems as well as the association of these conditions to some biological markers. 
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2 INTRODUCTION 
 
The overall aim was to explore biological markers associated with Attention-Deficit/ 
Hyperactivity Disorder (ADHD) and Disruptive Behavior Disorders (DBD). In 
discussion with Professor Oreland, Uppsala university, with a lot of experience of 
behavioural research on the genetic level, it was decided that we should investigate 
biological markers with regard to the serotonergic system, since many of the 
symptoms, which are included in the diagnoses, can be linked to activity of the 
serotonergic system. The decision became that Monoamine Oxidase B (MAO-B) 
enzyme activity in platelets and functional genotypes of the 5-HydroxyTryptamine 
Transporter gene-Linked Polymorphic Region (5-HTT LPR) and Monoamine Oxidase 
A Variable Number of Tandem Repeats (MAO-A VNTR) were analysed, since there 
are a lot of scientific reports that deviant behaviours, as well as indirect or direct 
effects on Central Nervous System (CNS) serotonergic activity, have been 
demonstrated for these biological factors (Deckert, Catalano et al. 1999; Gorwood, 
Batel et al. 2000; Oreland, Damberg et al. 2002; Lawson, Turic et al. 2003; Oreland 
2004; Oreland, Hallman et al. 2004; Paaver, Nordquist et al. 2007). 
 
In psychiatric disorders the correspondence between genotype and phenotype is not yet 
fully understood, and in this thesis the focus is on the association between these 
complex phenotypes of ADHD and DBD as well as various psychiatric symptoms and 
genotypes with regard to the serotonergic system. ADHD and DBD are commonly 
reported disorder and there are several studies focusing on their respectively etiology, 
while here they are studied together.  
 
The diagnoses of psychiatric disorder phenotypes are based on assessment of symptoms 
and their clinical manifestation according to manuals for example Diagnostic and 
Statistical Manual of Mental Disorders 4th edition Text Revision (DSM-IV-TR), 
(American Psychiatric Association. and American Psychiatric Association. Task Force 
on DSM-IV. 2000). The assessment of the complex phenotypes and various 
psychiatric/psychological symptoms was based on a structured clinical interview with 
the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age 
Children-Present and Lifetime Version (K-SADS-PL).The K-SADS-PL is a widely 
used semi structured diagnostic interview designed to assess current and past episodes 
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of psychopathology in children and adolescent according to DSM-IV-TR. K-SADS-PL 
has been shown to be a reliable and valid diagnostic instrument for child and adolescent 
psychiatric diagnoses (Kaufman, Birmaher et al. 2000). 
 
In Paper I, there was an association between symptoms of deviant behaviour with 
respect to these separate biological markers. Paper II analysed a combination of these 
biological markers in relation to the phenotypes, and a more conclusively picture of 
ADHD and DBD emerged. Paper III found that the phenotypes of ADHD and DBD 
are not isolated conditions, however, they coexist with various psychiatric and 
behavioural problems as well as risk factors for addiction. Paper IV, found that these 
biological markers separately and in interaction are related to various psychiatric and 
behavioural problems. 
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3 BACKGROUND 
 
ADHD is one of the most common developmental disorders; it has two separate 
underlying dimensions; an inattentive dimension, associated difficulties in sustained 
attention, distractibility, disorganization and lack of task persistence, and a hyperactive-
impulsive dimension, including excessive activity and impulsive responding. Table 1 
presents the symptoms of ADHD, to fulfil the criteria 6/9 symptoms are required for 
ADHD inattentive, 6/9 symptoms are required to fulfil the criteria for ADHD 
hyperactive, ADHD combined type includes the criteria for both inattentive type and 
the hyperactive/impulsivity type according to DSM-IV-TR. DBD is a behavioural 
disorder and includes two dimensions Oppositional Defiant Disorder (ODD) and 
Conduct Disorder (CD). ODD characterized by a sustained pattern of chronic 
argumentativeness, and anger associated with compromised poor social relations with 
parents and peers. Table 2 presents the symptoms of ODD of which 4/8 are required for 
diagnosis according to DSM-IV-TR. CD characterized by a variety of persistent 
antisocial behaviours including acts of aggression, destruction of property, 
deceitfulness, theft and violation of commonly adhered to social norms. Table 3 
presents the symptoms of CD, of which 3/15 are required for diagnosis according to 
DSM-IV-TR. Consensus estimates suggest that ADHD affects 3-10%, ODD 1-5% and 
CD 1-5% of school aged children (Spencer, Biederman et al. 2002; Kutcher, Aman et 
al. 2004; Biederman 2005). ADHD and DBD are disabling and associated with high 
costs, both for society and in terms of individual suffering and often associated with 
various psychiatric/psychological problems and environmental factors (Faraone, 
Wilens et al. 2007; Freitag, Rohde et al. 2010; Froehlich, Anixt et al. 2011; Malmberg, 
Edbom et al. 2011). Aggressive behaviour and temperament is often associated with 
ADHD and DBD and impulsivity is including in the criteria for ADHD and aggression 
in CD (Schmeck and Poustka 2001; Hirshfeld-Becker, Biederman et al. 2002; Rettew, 
Copeland et al. 2004). 
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Table 1. Symptoms of ADHD in accordance with DSM-IV-TR 
A. Six (or more) of the following symptoms of inattention and/or six(or more) of 
hyperactive/impulsivity have been present for at least 6 months to a degree that is 
maladaptive and inconsistent with developmental level: 
 
Inattention 
1. often fails to give close attention to details or makes careless mistakes in schoolwork, 
work, or other activities 
2. often has difficulty sustaining attention in tasks or play activities 
3. often does not seem to listen when spoken to directly 
4. often does not follow through on instructions and fails to finish schoolwork, chores, or 
duties in the workplace (not due to oppositional behavior or failure to understand 
instructions) 
5. often have difficulty organizing tasks and activities 
6. often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental 
effort (such as schoolwork or homework) 
7. often loses things necessary for tasks or activities (eg, toys, school assignments, 
pencils, books, or tools) 
8. is often easily distracted by extraneous stimuli 
9. is often forgetful in daily activities 
 
Hyperactivity 
10. often fidgets with hands or feet or squirms in seat  
11. often leaves seat in classroom or in other situations in which remaining seated is 
expected 
12. often runs about or climbs excessively in situations in which it is inappropriate (in 
adolescents or adults, may be limited to subjective feelings of restlessness) 
13. often has difficulty playing or engaging in leisure activities quietly 
14. is often "on the go" or often acts as if "driven by a motor" 
15. often talks excessively 
 
Impulsivity 
16. often blurts out answers before questions have been completed 
17. often has difficulty awaiting turn  
18. often interrupts or intrudes on others (eg, butts into conversations or games) 
 
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment were 
present before age 7 years. 
C. Some impairment from the symptoms is present in two or more settings (e.g. at school 
or work and at home). 
D. There must be clear evidence of clinically significant impairment in social, academic or 
occupational functioning. 
E. The symptoms do not occur exclusively during the course of a Pervasive 
Developmental Disorder, Schizophrenia, or other Psychotic Disorder and are not better 
accounted for by another mental disorder (e.g. Mood Disorder, Anxiety Disorder, 
Dissociative Disorder, or a Personality Disorder. 
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Table 2. Symptoms of ODD in accordance with DSM-IV-TR 
A. A pattern of negativistic, hostile, and defiant behavior lasting at least 6 months, during 
which four (or more)  of the following are present: 
 
1. often loses temper 
2. often argues with adults 
3. often actively defies or refuses to comply with adults' requests or rules 
4. often deliberately annoys people 
5. often blames others for his or her mistakes or misbehavior 
6. is often touchy or easily annoyed by others 
7. is often angry and resentful 
8. is often spiteful or vindictive 
 
Note: Consider a criterion met only if the behavior occurs more frequently than is typically 
observed in individuals of comparable age and developmental level. 
 
B. The disturbance in behavior causes clinically significant impairment in social, 
academic, or occupational functioning. 
C. The behaviors do not occur exclusively during the course of a Psychotic or Mood 
Disorder. 
D. Criteria are not met for Conduct Disorder, and, if the individual is age 18 years or 
older, criteria are not met for Antisocial Personality Disorder. 
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Table 3. Symptoms of CD in accordance with DSM-IV-TR 
A. A repetitive and persistent pattern of behavior in which the basic rights of others or 
major age-appropriate societal norms or rules are violated, as manifested by the 
presence of three (or more) of the following criteria in the past 12 months, with at least 
one criterion present in the past 6 months. 
 
Aggression to people and animals 
1. often bullies, threatens, or intimidates others 
2. often initiates physical fights 
3. has used a weapon that can cause serious physical harm to others (e.g. , a bat, brick, 
broken bottle, knife, gun)  
4. has been physically cruel to people 
5. has been physically cruel to animals  
6. has stolen while confronting a victim (e.g., mugging, purse snatching, extortion, armed 
robbery)  
7. has forced someone into sexual activity  
 
Destruction of property 
8. has deliberately engaged in fire setting with the intention of causing serious damage 
9. has deliberately destroyed others' property (other than by fire setting) 
 
Deceitfulness or theft 
10. has broken into someone else's house, building, or car 
11. often lies to obtain goods or favors or to avoid obligations (i.e., "cons" others) 
12. has stolen items of nontrivial value without confronting a victim (e.g., shoplifting, but 
without breaking and entering; forgery) 
 
Serious violations of rules 
13. often stays out at night despite parental prohibitions, beginning before age 13 years 
14. has run away from home overnight at least twice while living in a parental or parental 
surrogate home (or once without returning for a lengthy period) 
15. is often truant from school, beginning before age of 13 years 
 
B. The disturbance in behavior causes clinically significant impairment in social, 
academic or occupational functioning. 
C. If the individual is aged 18 years or older, criteria are not met for Antisocial Personality 
Disorder. 
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3.1 SUBTHRESHOLD DIAGNOSIS AND DIMENSIONAL SCALE OF 
SYMPTOMS 
In child and adolescent psychiatry there has been increasing interest in the distinction 
between subthreshold and full syndrome disorders, and specifically whether 
subthreshold conditions develop into or predict the onset of full syndrome disorders 
over time. Diagnosing ADHD in adolescents could be difficult if the clinician cannot 
establish the onsets prior to the DSM-IV-TR criterion of age seven years or if the 
number of symptoms is below the DSM-IV-TR threshold for diagnosis. In a series of 
papers the validity of atypical groups has been discussed: patients who meet all the 
criteria for ADHD except for age and onset and patient who exhibit impairing ADHD 
and DBD symptoms that do not exceeded the DSM-IV-TR threshold criteria (Faraone, 
Biederman et al. 2006; Faraone, Biederman et al. 2006). 
 
The symptoms in the DSM-IV-TR are categorical diagnoses of ADHD and DBD. In a 
15-year longitudinal study of subthreshold psychiatric conditions conducted with young 
adults Shankman et al. (Shankman, Lewinsohn et al. 2009) reported that subthreshold 
major depression, bipolar disorder, anxiety disorders, alcohol use, substance use, CD 
and/or ADHD were precursors of the corresponding full syndrome disorder and that 
subthreshold conditions were precursors for other full syndrome; and persisted after 
adjusting for comorbidity. Thus, many subthreshold conditions have predictive validity 
as they may represent precursors of full syndrome disorders and are therefore good 
targets for preventive interventions. 
 
Another way of describing diagnoses is to use a dimensional scale of symptoms, i.e. the 
summary scores of symptoms for developmental or psychiatric diagnoses. Many 
clinicians believe that a dimensional scale of symptoms is a better way to describe 
psychopathology (Rubio-Stipec, Walker et al. 2002; Thapar, Langley et al. 2006). 
 
It is important to have broader conceptualizations of dimensions of symptoms as well 
as categorical and subthreshold diagnoses of psychiatric disorders, such as studying a 
spectrum of externalizing psychopathology when identifying susceptibility genes and 
understanding the pathways through which genetic factors affect vulnerability to a 
variety of poor outcomes. 
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3.2 ADHD, DBD AND COMORBIDITY 
Individuals with ADHD are at greater risk of poor educational attainment, lower 
income, underemployment, problems with the law, and impaired social relationships 
(Barkley 2002; Ek, Westerlund et al. 2011). Children with ADHD have a high risk of 
coexisting conditions such as DBD (Kutcher, Aman et al. 2004). ODD is a significant 
precursor of adolescent CD in children with ADHD, irrespective of ADHD severity 
(Barkley 2004; Whittinger, Langley et al. 2007; Taylor 2010). There is a negative 
prognosis for children with ADHD and comorbid CD, in addition to increased risk of 
criminality and drug abuse in adolescence and adulthood (Hirshfeld-Becker, Biederman 
et al. 2002; Hazell 2010; Heffner, Johnson et al. 2010). A high degree of overlap has 
been found between CD and ODD, both in terms of epidemiology and shared risk 
factors, such as low socioeconomic status, parental antisocial personality (ASP) 
disorder, and deficient parenting. 
 
In a reviewed article by Freitag et al (Freitag, Rohde et al. 2010), up to 90% of the 
children with ADHD suffered from at least one comorbid disorder. The most prevalent 
comorbid disorders reported were ODD (40–65%), CD (27–47%), major depressive 
disorder (MDD; 0–24%) and generalized anxiety disorder (GAD; 13–21%). This is in 
agreement with findings from other studies showing that patients with ADHD had a 
higher risk than the control group of developing ODD, CD, tic disorder, mood 
disorders, anxiety disorders, specific phobias as well as ever tried and regular use of 
nicotine (Biederman, Newcorn et al. 1991; Barkley 2004; Faraone, Wilens et al. 2007). 
 
ADHD and DBD have been described as risk factors for addictive behaviour such as 
smoking, high consumption of alcohol and other drugs (Faraone, Wilens et al. 2007; 
Heffner, Johnson et al. 2010). Moss et al. (Moss and Lynch 2001) demonstrated that 
symptoms of CD were associated with alcohol use disorder symptoms in adolescents. 
ASP disorder symptoms predict deterioration in global adaptive functioning, while the 
number of arrests, early-onset severe externalizing pathology and the quality of peer 
relationships (Biederman, Petty et al. 2010) are symptoms of DBD with onset in 
childhood/adolescence. The comorbid conditions that coexist with childhood ADHD 
often continue into adulthood (Shankman, Lewinsohn et al. 2009; Biederman, Petty et 
al. 2010). 
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3.3 ADHD, DBD AND HERITABILITY 
Evidence from family, twin, and adoption studies suggest that genetic factors 
substantially contribute to the development of ADHD and several reports have 
indicated genetic factors add to the etiology of the disorder and that the susceptibility of 
the phenotype occurs in interaction between genotype and environmental risk factors in 
complex ways (Larsson, Larsson et al. 2004; Larsson, Lichtenstein et al. 2006; Coghill 
and Banaschewski 2009; Freitag, Rohde et al. 2010; Anokhin, Golosheykin et al. 2011; 
Froehlich, Anixt et al. 2011). A strong genetic component in the pathogenesis of 
ADHD with an estimated heritability of 70-80% has been reported (Biederman 2005). 
Evidence from behavioural genetics supports the conclusion that a significant amount 
of the variance in ASP and behaviour is due to genetic contributions (Biederman 2005; 
Ferguson 2010). 
 
3.4 GENETICS  
It is now generally agreed that many different genes are involved in personality. If a 
gene can explain 2% of a disorder that is a rather big effect and it is now holding that 
probably ever gene has very small effect for example 0.1% in explaining a disorder and 
it is often a combination of genes that are responsible for vulnerability for disorders. 
Biological and behavioural research is linked to genetics and the past three decades 
have witness the most dramatic changes in behavioural studies. Acceptance of the 
genetic influence in behavioural research has been due to an increasing number of 
scientific papers and popular books. There are different techniques of analysing genes. 
Genetic influence does not mean that the environment is unimportant. The 
corresponding between the environmental factors and the genetics are shown in Fig. 1. 
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Fig. 1 Genes and environmental factors influence, and are dependent on and independent of 
each other, and how different genetic markers can be analysed. 
 
3.4.1  Candidate genes and neurotransmitter 
Examples of risk factors are specific candidate genes, genes that control the transmitter 
substance in CNS. A candidate gene is any gene considered likely to cause a disease. It 
may be a candidate because it is located in a particular chromosome region suspected of 
being involved in the disease or its protein product may suggest that it could be the 
disease gene in question. A candidate gene can also be identified by association with 
the phenotype and by linkage analysis to a region of the genome. A neurotransmitter is 
a chemical that is released from neurons in order for signals to be passed from one 
neuron to another in the CNS. Lack of communication between neurons can lead to a 
number of physical and mental disorders. 
 
3.4.2 Dopaminergic system 
Dopamine (DA) is the neurotransmitter that regulates the system that plays an 
important function in learning, motivation, goals, drives, reward and emotion all of 
which are crucial to survival. There are five known types of DA receptors (DRD) —D1, 
D2, D3, D4, and D5 —and their variants. DA is produced in several areas of the brain, 
including the substantia nigra and the ventral tegmental area. DA is also a 
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neurohormone released by the hypothalamus and its main function as a hormone is to 
inhibit the release of prolactin from the anterior lobe of the pituitary.  
 
Converging evidence has implicated abnormalities of DA neurotransmission to the 
pathology of ADHD and there is increasing evidence of reward-motivation deficits in 
this disorder. The inattention associated ADHD could stem in part from 
understimulation of reward and motivation centers in the brain. A reduction in DA 
synaptic markers associated with symptoms of inattention was shown in the dopamine 
reward pathway of participants with ADHD (Levy 1991; Volkow, Wang et al. 2009). 
 
3.4.3 Noradrenergic system 
Noradrenaline (NA) is the neurotransmitter involved in the detection of stimuli that are 
important for the alertness and readiness necessary to process such stimuli. The 
noradrenergic system originates in brain stem structures, such as the locus 
ceruleus, and in the area behind the locus ceruleus called the medulla. One part of 
this called the dorsal ascending system, which projects throughout the forebrain, 
including the neocortex and the hippocampus but the striatum. It is really turned on 
by novelty. Excess stimulation, including too much novelty, may cause stress that 
can be linked to anxiety. 
 
3.4.4 Serotonergic system 
Serotonin or 5-hydroxyTryptamine (5-HT) was first described as a vasoconstrictor 
compound in serum and later identified as a neurotransmitter (Rapport, Green et al. 
1948; Gaddum 1953; Twarog and Page 1953). Serotonin is primarily found in the 
gastrointestinal tract, platelets, and in the CNS of animals including humans. Central 
serotonergic neurons originate from the raphe nuclei in the brainstem and innervate 
major brain regions, such as the hypothalamus, the limbic system, the striatum, and 
the neocortex. The serotonin system is involved in several vital functions like 
attention, memory, motivation, emotions, behaviour, appetite, and sleep. Serotonin is 
mainly metabolized to 5-Hydroxyindoleacetic acid (5-HIAA). 5-HT is a monoamine 
neurotransmitter biochemically derived from tryptophan. Metabolism involves first 
oxidation by MAO to the corresponding aldehyde followed by oxidation by aldehyde 
dehydrogenase to 5-HIAA which is a marker for serotonin turnover (Placidi, 
Oquendo et al. 2001). Serotonin is stored in vesicles until release into synaptic cleft 
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where it binds to receptors and is reuptaken into the cell via serotonin transporter 
gene 5-HydroxyTryptamine Transporter (5-HTT). 
 
Two key genes expressing proteins of major importance for serotonergic activity are 
the genes encoding the 5-HTT and the MAO-A enzyme. Both of these genes have 
functional promoter polymorphisms that have been shown to be associated with 
behaviour: the 5-HTT LPR and the MAO-A VNTR (Lesch, Bengel et al. 1996; 
Deckert, Catalano et al. 1999). 
 
3.4.4.1 Serotonin transporter gene (SLC6A4; 5-HTT)  
The serotonin transporter gene 5-HTT is located on the long arm of chromosome 17. It 
codes for a solute carrier protein responsible for the reuptake of serotonin from the 
synaptic cleft back into the presynaptic neuron and thus represents a primary 
mechanism for the regulation of serotonergic activity in the brain. 5-HTT is expressed 
in brain regions such as the amygdala, hippocampus, thalamus, putamen, and anterior 
cingulate cortex. It represents a functional candidate for ADHD, which is further 
supported by studies suggesting its involvement in the etiology of impulsivity and in 
modulating stimulant response in alleviating hyperactivity (Seeger, Schloss et al. 2001; 
Zoroglu, Erdal et al. 2002; Faraone, Perlis et al. 2005). 
 
A polymorphism in the 5-HTT LPR with the short allele (s) having lower in vitro 
transcriptional activity than the long allele (l), has been associated with personality 
traits (Canli and Lesch 2007). This polymorphism in the promoter region of the gene 5-
HTT LPR is one of the most frequently studied genetic markers in psychiatric genetic 
research and has been extensively tested for association with depressive and anxiety 
disorders and related traits. The 5-HTT LPR is a 44-bp insertion/deletion yielding long 
and short alleles. The long variant is associated with more rapid serotonin reuptake 
resulting in lower levels of active serotonin, whereas the short variant appears to be 
associated with reduced serotonin reuptake resulting in higher levels of active serotonin 
(Heils, Teufel et al. 1995; Lesch, Bengel et al. 1996). 
 
3.4.5 Monoamine Oxidase  
MAO is the best understood enzyme associated with central monoamine transmitter 
systems. MAO proteins exist in two forms, MAO-A and MAO-B, which metabolises 
monoamines, DA, NA, and serotonin. Both enzymes are expressed in human tissues 
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however, only MAO-B is expressed inhuman platelets and therefore, in contrast to 
MAO-A, its activity is readily accessible for estimation in venous blood samples. 
MAO-A plays a major role in the degradation of the monoamine transmitters NA and 
serotonin in the human brain, while MAO-B plays a greater role in the degradation of 
DA (Oreland 1991). 
 
3.4.5.1 MAO-A 
The MAO-A gene is located on the X-chromosome (Xp11.23–11.4) and codes for an 
enzyme (MAO-A; EC 1.4.3.4), which is involved in the metabolism of biogenic 
amines including DA, NA and serotonin. The X-linked MAO-A gene harbours a 
variable number of tandem repeats (VNTR). Short alleles (3 repeats) show less MAO-
A activity than long alleles (>3 repeats) (Deckert, Catalano et al. 1999). MAO-A 
VNTR has been linked to personality traits and deviant behaviour (Manuck, Flory et al. 
2000; Meyer-Lindenberg, Buckholtz et al. 2006). 
 
More specific support for MAO-A as a candidate gene for ADHD comes from a 
linkage study conducted in a large Dutch family demonstrating a relation between 
MAO-A and impulsive, aggressive behaviour (Brunner, Nelen et al. 1993). Studies 
have mainly focused largely on a functional 30-bp VNTR 1.2 kb upstream of the gene 
that has been associated with impulsivity and aggression (Manuck, Flory et al. 2000; 
Caspi, McClay et al. 2002). This polymorphism consists of alleles of 2, 3, 3.5, 4 and 5 
copies with evidence suggesting the 2 and 3 repeat alleles to be less efficiently 
transcribed than the longer ones (Deckert, Catalano et al. 1999). There is some 
evidence to suggest that the 5-repeat allele also results in less efficient transcription 
(Sabol, Hu et al. 1998; Meyer-Lindenberg, Buckholtz et al. 2006). Nevertheless, the 
majority of studies testing for association between this polymorphism and ADHD have 
relied on the classification system described by in which the 2- and 3-repeat alleles are 
considered ‘low-activity’ alleles and the 3.5-, 4- and 5-repeat alleles are considered 
‘high-activity’ (Deckert, Catalano et al. 1999). 
 
3.4.5.2 MAO-B 
MAO-B is present in platelets where its activity has been suggested to be a marker for 
the monoaminergic capacity in the brain (Oreland 2004; Oreland, Hallman et al. 2004). 
Low platelet MAO-B activity correlates with personality traits such as sensation 
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seeking, impulsiveness and monotony avoidance, and has also been associated with 
deviant behaviour such as type II alcoholism. Low MAO-B activity has been linked to 
ADHD (Shekim, Bylund et al. 1986) and temperament (Oreland 2004). The 
relationship between novelty seeking and MAO-B and externalizing psychopathology 
is described in the literature (Ruchkin, Koposov et al. 2005). Platelet MAO-B activity is 
highly heritable (>76%) and stable over time (Pedersen, Oreland et al. 1993). Low 
platelet MAO-B activity does not directly predispose individuals to psychopathology 
but is related to specific personality traits, and has had a great impact on the 
understanding of the nature of constitutional factors that render individuals 
vulnerable. Smoking inhibits MAO-activity in platelets, and is a confounding factor 
that was not controlled for in previous studies (Oreland, Damberg et al. 2002). 
 
3.4.6 ADHD, DBD and candidate genes  
ADHD can be considered a disorder with particular focus on the neurotransmitters DA 
and NA (Faraone, Perlis et al. 2005; Wohl, Purper-Ouakil et al. 2005). With regard to 
the serotonergic system, there are studies reporting involvement of serotonin in the 
etiology of ADHD (Halperin, Newcorn et al. 1997; Lucki 1998; Seeger, Schloss et al. 
2001; Hawi Z, Dring M et al. 2002; Heiser, Dempfle et al. 2007). Genetic, 
developmental and neuro-biological factors are known to play an important role in the 
emergence of aggressive behaviour, substance abuse, as well as family and marital 
discord (Farrington and Loeber 2000). Several neurotransmitter systems such as 
serotonin, DA and NA were suspected of being involved in aggression (Dolan, 
Anderson et al. 2001; Nelson and Chiavegatto 2001). Serotonergic components are 
involved in several behavioural traits such as aggression and impulsiveness, which are 
frequently associated with ADHD and DBD (Brunner, Nelen et al. 1993; Halperin, 
Newcorn et al. 1997; Mitsis, Halperin et al. 2000; Seeger, Schloss et al. 2001; Hawi Z, 
Dring M et al. 2002; Lawson, Turic et al. 2003; Zammit, Jones et al. 2004; Wohl, 
Purper-Ouakil et al. 2005; Heiser, Dempfle et al. 2007; Grigorenko, De Young et al. 
2010). 
 
A range of candidate genes, such as 5-HTT, MAO-A Dopamine Receptor 1-4 (DRD1-
DRD4) has been implicated in psychiatric comorbidity (Cerda, Sagdeo et al. 2009). 
Polymorphisms in three DA loci (DRD4, DRD5, Dopamine Transporter (DAT)) are 
the most frequently replicated molecular correlates of ADHD (Faraone, Perlis et al. 
2005). Reports are inconsistent with regard to associations between ADHD-like 
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behaviours and the 5-HTT LPR or MAO-A VNTR, (Manor, Tyano et al. 2002; 
Lawson, Turic et al. 2003; Domschke, Sheehan et al. 2005; Lung, Yang et al. 2006; 
Heiser, Dempfle et al. 2007; Qian, Liu et al. 2009; Baker, Prevatt et al. 2011). 
 
In the present study 5-HTT LPR was studied as well as MAO-A genes and MAO-B 
activity in platelets in addition to ADHD, DBD and psychiatric symptoms. These two 
key genes express proteins of major importance for serotonergic activity. Both have 
functional promoter polymorphism 5-HTT LPR and MAO-A VNTR, which has been 
found to be associated with behaviour such as anxiety and associated with the risk for 
substance use disorders (Sabol, Hu et al. 1998; Deckert, Catalano et al. 1999; Lesch 
2005). The low activity variant in both 5-HTT LPR and MAO-A VNTR genes confers 
vulnerability to deviant behaviour. Studies on humans indicate  that the short, and thus 
presumably less active, variant of this MAO-A VNTR polymorphism seems to interact 
with environmental factors such as childhood maltreatment in explaining male 
adolescent delinquency (Caspi, McClay et al. 2002; Foley, Eaves et al. 2004; Nilsson, 
Sjoberg et al. 2005). Lower serotonergic activity responsively assessed in childhood 
predicted the development of ASP disorder (Flory, Newcorn et al. 2007). Research has 
suggested that trait-impulsivity and aggressiveness in ADHD could be potential 
moderators of serotonin-dependent aggressive behaviour in children and adolescents 
(Zepf 2010). 
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4 AIMS 
 
The overall aim was to study symptoms of ADHD and DBD, including ODD and CD 
in adolescence and their relationships with candidate genes 5-HTT and MAO-A as well 
as MAO-B activity in platelets. 
 
4.1 PAPER I 
To study whether subthreshold diagnosis and dimensional symptoms of ADHD and 
DBD phenotypes are associated with MAO-B activity in platelets and polymorphism in 
MAO-A VNTR and 5-HTT LPR genotypes. 
 
4.2 PAPER II 
To study the association between ADHD and DBD phenotypes with regard to the 
combination of platelet MAO-B activity and MAO-A VNTR or 5-HTT LPR genotype. 
 
4.3 PAPER III 
The aim was to study how subthreshold diagnoses of ADHD_comb and DBD are 
related to other symptoms of child and adolescent psychiatric disorders and risk 
behaviours related to smoking, alcohol and various drugs. 
Specific aims: 
1. The prevalence of possible or certain symptoms in boys and girls revealed by 
the screening questions in the Kiddie-SADS-Present interview. 
2. The relationship between subthreshold diagnoses of ADHD/DBD and the 
screening questions for other psychiatric problems in the K-SADS-PL using 
odd ratios. 
3. The relationship between subthreshold diagnoses of ADHD/DBD and smoking, 
alcohol and drug use. 
 
4.4 PAPER IV 
Instead of using the DSM-IV-TR classification based on categorical diagnoses the 
purpose was in the present study to study how separate psychiatric and behavioural 
symptoms based on the K-SADS-PL interviews were related to platelet MAO-B 
activity and polymorphism in the 5-HTT LPR genotype. The aim was to study the 
association between symptoms and the individual biological markers and combinations 
of these markers. 
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5 METHODS 
 
5.1 STUDY GROUP 
The participants were part of the population-based Swedish Twin study of CHild and 
Adolescent Development (TCHAD) (Lichtenstein, Tuvblad et al. 2007), a longitudinal 
study of all 1481 twin pairs born in Sweden between May 1985 and December 1986. 
They were followed in four waves of measurements targeting the whole population and 
by a clinical investigation of a sub-sample from childhood (8 years) into adulthood 
(21–22 years) (Larsson, Larsson et al. 2004; Edbom, Malmberg et al. 2010). Papers I-
IV is part of the TCHAD study, although twin methodology was not used. The clinical 
investigation was conducted on the twin pairs from the TCHAD study who resided in 
the Stockholm area in 2001-2002. Out of the 271 twin pairs originally invited to 
participate in the study, 156, i.e. 312 individuals (135 boys and 177 girls), and one or 
both parents took part in the interview. Blood was drawn from 247 individuals and 
genetic association was analysed from 197 individuals. The mean age was 16 years, 
ranging from 14.6 to 16.7 years. The 115 twin pairs, i.e. 230 individuals who did not 
participate, either declined (67 twin pairs, i.e. 134 individuals) or failed to answer the 
telephone call or a letter (48 twin pairs, i.e. 96 individuals). The most common reason 
for declining was lack of time on the part of the parents and in a few cases the reason 
stated was that one of the twins was disabled. A sample selection procedure is 
presented in Fig. 2. 
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Fig.  2 Sample selection procedures 
 
Of the 312 individuals, 65% lived with two parents, 34% with one parent and 1% in 
foster care. Academic qualifications were reported for 55% of the mothers and 49% of 
the fathers. 80% of the individuals had parents of Swedish origin, 14% had one parent 
who was an immigrant and, in the case of 6%, both parents were immigrants. The 
participants in the study were born in Sweden, as requirements for inclusion in the 
Swedish twin registry are born in Sweden and both twins being alive. 
 
5.2 CLINICAL INTERVIEW 
The K-SADS-PL is a widely used semi-structured diagnostic interview designed to 
assess current and past episodes of psychopathology in children and adolescents in 
accordance with the DSM-IV-TR criteria. K-SADS-PL has been shown to be a reliable 
and valid diagnostic instrument for child and adolescent psychiatric diagnoses and is 
divided into a screening interview and five diagnostic supplements (Kaufman, 
Birmaher et al. 2000). 
 
271 twin pairs living in Stockholm area 
156 (312 individuals) twin pairs 
agreed to a clinical investigation  
and assessment 
 
female=177 male=135
115 twin pairs 
 did not want to participate (67 families)
 or failed to answer letter or 
 telephone call (48 families) 
Sample of genetic association analyses 
 
female=105 male=92
247 individuals complete data with blood test 
 
female=142 male=105
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The twin pairs and their parents were invited to an assessment including a structured 
interview based on the K-SADS-PL (Kaufman 1996). In this study, the Swedish K-
SADS-PL present version (Ivarsson 2010) was used to assess the symptoms in 
accordance with DSM-IV-TR. Each individual was interviewed separately. The 
interviewer assessed the information from one of the parents and the children and 
classified the symptoms as “not present” (0), “possible” (1) or “certain” (2) and 
trauma, drugs, alcohol and smoking as” yes” or “no”. The interview with parents in 
most cases involved the children’s mother. 
 
For the purpose of the study, the symptoms included in the criteria for ADHD subtypes, 
ODD and CD were assessed according to K-SADS-PL and compiled in three ways:  
 
1. Dimensional scales of the symptoms i.e., the summary scores of symptoms included 
in the criteria for the following diagnoses (scaled 0-2) were calculated: ADHD 
inattentive type, ADHD hyperactive type, ADHD combined type, ODD, CD and a 
combined scale for CD and ODD. 
 
2. DSM-IV diagnostic criteria were applied using the information from K-SADS-PL. 
Each symptom was counted if the item was assessed as “certain” by the interviewer 
leading to the following diagnoses: ADHD inattentive type, ADHD hyperactive type, 
ADHD combined type (ADHD_comb), ODD, CD and CD or ODD combined (Table 
4). 
 
3. The symptoms of the diagnoses described in 1 and 2 were also dichotomized. DSM-
IV diagnostic criteria were applied as follows; the individual child was regarded as 
having “subthreshold diagnosis” if the symptom was assessed as “possible” or “certain” 
using the same diagnostic criteria as in 2 above (Table 4). 
 
 28 
Table 4. ADHD and DBD derived from K-SADS -PL interviews in a population-based 
sample of adolescents 
Diagnosis Girls Boys Total 
 n/N* (%) n/N* (%) n/N* (%) 
Threshold       
ADHD inattentive 4/174 2.3 4/134 3.0 8/308 2.6 
ADHD hyperactive 2/173 1.2 7/134 5.2 9/307 2.9 
ADHD combined 0/173 0.0 1/134 0.8 1/307 0.3 
ODD 1/173 0.6 2/133 1.5 3/306 1.0 
CD 1/174 0.6 1/133 0.8 2/307 0.7 
CD or ODD 2/173 1.2 2/133 1.5 4/306 1.3 
Subthreshold**       
ADHD inattentive 29/174 16.7 42/134 31.3 71/308 23.1 
ADHD hyperactive 21/173 12.1 25/134 18.7 46/307 15,0 
ADHD combined 13/173   7.5 16/134 11.9 29/307   9.5 
ODD 23/173 13.3 19/133 14.3 42/306 13.7 
CD   9/174   5.2 15/133 11.3 24/307   7.8 
CD or ODD  25/173 14.5 25/133 18.8 50/306 16.3 
 
*Number of children fulfilling criteria for diagnosis or subthreshold diagnosis/total 
number of children  
**Subthreshold diagnosis based on possible and certain symptoms 
 
 
5.2.1 Children Global Assessment Scale  
To study the validity of subthreshold diagnoses were used by the Children Global 
Assessment Scale (CGAS) a scale for children very similar with the Global Assessment 
of Functioning in DSM-IV (Shaffer, Gould et al. 1983).  
 
The CGAS scores were significantly lower (p-values from 0.01 to 0.049) in the 
children with each subtype of subthreshold diagnosis of ADHD phenotype (inattentive, 
hyperactivity and combined types) and DBD (ODD, CD and ODD or CD) compared to 
children without diagnosis. 
 
5.3 GENOTYPING AND MAO-B ACTIVITY MEASUREMENT 
Blood samples were obtained from 247 individuals (123 twin pairs and one individual), 
106 boys and 141 girls, and genomic DNA was isolated by standard methods. For 
MAO-B activity measurement, platelet rich plasma was prepared by low-speed 
centrifugation, 200 x g for 10 minutes. Platelet concentration of the plasma samples 
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were estimated electronically and the plasma was stored at -80C. PCR-based 
genotyping was performed as described for MAO-A VNTR (Nilsson, Sjoberg et al. 
2007) and 5-HTT LPR (Collier, Stober et al. 1996). The MAO-A and 5-HTT PCR 
products were analyzed by electrophoresis on 2 % agarose gels and visualized under 
UV light by ethidium bromide staining. Genotypes were based on two separate 
readings. 
 
Because the MAO-A gene is X linked, only boys were included in the MAO-A VNTR 
analysis. Having two X chromosomes, girls can be heterozygous and cannot be 
functionally characterized with certainty because it is impossible to know which of the 
two alleles is inactivated.  
 
Catalytic activity of platelet MAO-B was analyzed with C14-labelled 2-
phenylethylamine (-PEA) as substrate. Before analysis, the samples of platelet rich 
plasma were thawed and sonicated at 0C for 5x10 seconds with intervals of 5 seconds 
for lysis of the platelets. 50 l of the plasma was added to 50 l of 0.1 mM 14C--PEA 
(0.5 Ci/ml) in 0.1 M sodium phosphate buffer. The reaction mixture was incubated at 
37C for 4 minutes, and the reaction terminated by the addition of 30 l 1 M HCL. 
Thereafter, the radioactive aldehyde product formed was extracted by shaking for 30 
seconds into 750 l toluene: ethylacetate (1:1). The samples were then centrifuged at 
room temperature for 5 minutes at 1000 x g. The organic phase (500 l), containing the 
aldehyde product was pipetted into vials with 8 ml scintillation fluid and the amount of 
radioactive aldehyde product subsequently quantified by scintillation analysis. Enzyme 
activity is expressed as nmol of substrate oxidized per 1010 platelets per minute. All 
samples were analyzed blindly and in duplicate. 
 
5.4 SMOKING 
Compounds in cigarette smoke exert inhibitory effect on MAO activity, but are only 
reported to be significant in quantities exceeding 300 cigarettes per month (Snell, Glanz 
et al. 2002). Information about cigarette smoking was obtained by asking the subjects at 
the time of the blood sampling whether they had smoked in the past 24 hours (10% 
boys, 11% girls). This information was used as a covariate in the statistical analyses of 
the relationships between behaviour and platelet MAO-B activity. The K-SADS-PL 
inventory also contains questions about smoking habits as well. Smoking more than 
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two cigarettes per day were used as a cut off (11% boys, 12% girls). In order to further 
explore the possible effects of smoking on our results, subjects with positive smoking 
information from K-SADS-PL were, for the statistical analyses, combined with the 
group who had answered the question that they had smoked in the 24 hours prior to the 
blood test. 
 
5.5 STATISTICAL ANALYSES 
The main behavioural symptoms ADHD, ODD and CD, included either as categorical 
variables (subthreshold diagnosis) or dimensional scales, were analyzed with respect to 
their association with MAO-B activity in platelets and genotype of the MAO-A VNTR 
and the 5-HTT LPR. Separate analyses were performed for boys and girls. For these 
analyses the generalized linear model (GLM) in the Stata statistical software package 
was used (StataCorp 2005). Standard errors were adjusted for clustering within twin 
pairs by increasing the estimated standard errors, thus providing robust estimates of for 
example p-values. The method is based on the sandwich or Huber/White variance 
estimator a method available in Stata 9.0 and 11.0. The descriptive analysis of the data 
presented in the tables includes the entire sample. 
 
However, in the genetic association analyses one of the children in each pair of 
monozygotic (MZ) twins was randomly excluded from the statistical analyses (n=51), 
as MZ twins share all genetic risk factors which makes it somewhat uncertain whether 
the adjustment of standard errors, as described above, is correct for these subjects.  
 
The dimensional measures of ADHD, ODD and CD problems had skewed 
distributions. Therefore, non-parametric bootstrap tests were performed using the GLM 
model in Stata. In the GLM analyses, when calculating the relationships between 
behavioural problems and the 5-HTT genotype, the nominal scale included three 
variants (long-long, long-short and short-short alleles). This nominal scale was 
transformed into three index variables and employed in the GLM analyses using one of 
the variants as the reference variable (omitting this variable) in Paper I and II. In each 
of the GLM analyses of platelet MAO-B activity, the information about cigarette 
smoking  at the time for the blood sampling (whether they had smoked within the past 
24 hours), and from the K-SADS-PL was included as a covariate; smoking (yes/no). In 
the case of dimensional ADHD/DBD scales the association between sex and 
polymorphisms in the 5-HTT genotypes was analysed using GLM. In the same way the 
   
  
  31 
relation between sex and platelet MAO-B activity was studied. Children with missing 
values for two or more symptoms included in the criteria for each of the diagnoses in 
this study (ADHD subtypes, ODD and CD respectively) were excluded from the 
analyses. If there was missing values for only one of the symptoms in each of the 
diagnoses it was recorded as "no symptom." 
 
In Paper IV where β-coefficient and Confidence Interval (CI) calculated using logistic 
regression, and a p-value <0.05 was considered statistically significant. Standard errors 
were adjusted for clustering within twin pairs. The study subjects were calculated with 
MAO-B and 5-HTT LPR genotype separately and in combination. The 5-HTT LPR 
genotypes were analysed using the specific 5-HTT polymorphism and compared with 
the rest of the sample with the other 5-HTT polymorphism (ll compared to ls+ss, ls 
compared to ll+ss, ss compared to ll+ls). A multiplicative interaction model was used 
to analyse the combination of MAO-B as a continuous variable and the specific 5-HTT 
polymorphism. 
 
The study was approved by the ethics committee at Karolinska Hospital, Stockholm, 
Sweden, and in all cases the participating parent and the teenagers gave their written 
informed consent. 
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6 SUMMARY OF RESULTS 
 
6.1 PAPER I 
With regard to the 5-HTT LPR genotype, 41% carried two copies of the long allele, 
16% two copies of the short, and 43% were heterozygous. The genotype distribution of 
our sample did not deviate significantly from the Hardy-Weinberg equilibrium. 
 
The platelet MAO-B activity range was 4.0-19.2 nmol/min/1010 in boys and 6.3-23.7 
nmol/min/1010 in girls. Boys had significantly lower mean MAO-B activity than girls 
(p<0.001). 
 
Girls 
There were an association between low platelet MAO-B activity and symptoms of 
ODD and ODD or CD (Table 5). The heterozygote long/short 5-HTT LPR genotype 
and symptoms of CD for dimensional scale. There were no associations between the 5-
HTT LPR genotypes and the subthreshold diagnoses in girls. 
 
Table 5. Subtreshold diagnoses of ADHD/DBD and activity of MAO-B in platelets in 
girls 
Subthreshold 
diagnosis 
With 
diagnosis 
Without 
diagnosis 
n/N* p† p‡ 
 
 M(sd) M(sd)    
ADHD inattentive 12.57(2.40) 13.31(3.53) 22/140 0.371 0.485 
ADHD hyperactive 11.99(2.32) 13.32(3.47) 15/139 0.164 0.095 
ADHD combined 11.97(1.95) 13.25(3.45) 8/139 0.424 0.176 
ODD 11.50(2.18) 13.44(3.46) 18/140 0.020 0.004 
CD 11.63(1.48) 13.26(3.42) 6/140 0.075 0.142 
ODD or CD 11.52(2.07) 13.47(3.48) 20/140 0.008 0.008 
 
*Number of children with subthreshold diagnosis/total number of children 
† Analyses performed using subthreshold diagnosis  
‡ Analyses performed using dimensional scales  
 
Boys 
The heterozygote 5-HTT LPR genotype in boys was found to be related to symptoms 
of CD which were true for both dimensional scale of symptoms and subthreshold 
diagnosis Hemizygosity for the short MAO-A VNTR allele was associated with 
symptoms of DBD (Table 6 and 7). 
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Table 6. Dimensional symptom scales and subthreshold diagnosis of ADHD and DBD 
related to the 5-HTT LPR genotype in boys 
*Total number with the specific genetic marker 
**Number of children fulfilling diagnostic criteria/total number with the specific genetic marker  
***Subthreshold diagnosis according to possible and certain symptoms 
†SS and LL compared 
‡LS and LL compared 
 
 
Table 7. Subthreshold diagnoses of ADHD/DBD and the MAO-A VNTR genotype in 
boys 
Subthreshold diagnosis** Long 
4 repeat 
Short 
3 repeat 
p† 
 
p‡ 
 
ADHD inattentive 21/71 12/35 0.641 0.348 
ADHD hyperactive 9/70 8/35 0.241 0.185 
ADHD combined 7/70 6/35 0.353 0.202 
ODD 8/70 9/35 0.082 0.288 
CD 5/70 6/35 0.119 0.292 
ODD or CD 9/70 12/35 0.021 0.249 
*Number of boys with high subthreshold diagnosis/total number with the specific genetic 
marker 
**Subthreshold diagnosis according to possible and certain symptoms  
†Analyses performed using subthreshold diagnosis  
‡Analyses performed using dimensional scale  
Dimensional 
symptom scale 
SS 
short/short 
*n=12 
LS 
long/short 
n=47 
LL 
long/long 
n=45 
p† p‡ 
 Mean (S.D.)   
ADHD inattentive 4.17(3.10) 6.08(4.25) 4.09(3.73) 0.867 0.122 
ADHD hyperactive 3.17(3.43) 4.71(4.00) 3.02(2.97) 0.990 0.089 
ADHD combined 7.33(6.05) 10.79(7.04) 7.11(6.43) 0.928 0.064 
ODD 1.00(1.48) 2.17(2.82) 1.24(2.05) 0.817 0.079 
CD 1.08(1.68) 1.49(2.47) 0.42(1.08) 0.328 0.006 
ODD or CD 2.08(2.64) 3.66(4.90) 1.67(2.86) 0.651 0.018
Subthreshold 
diagnosis*** 
SS 
short/short 
LS 
long/short 
LL 
long/long 
p† p‡ 
 n/N**   
ADHD inattentive 3/12 17/48 12/45 0.905 0.333 
ADHD hyperactive 2/12 10/48 5/45 0.621 0.252 
ADHD combined 2/12 6/48 5/45 0.621 0.853 
ODD 1/12 11/47 5/45 0.790 0.150 
CD 1/12 9/47 1/45 0.350   0.035 
ODD or CD 2/12 14/47 5/45 0.630 0.049
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6.2 PAPER II 
In this paper a combination of platelet MAO-B activity and MAO-A VNTR or 5-HTT 
LPR genotypes were associated with subthreshold ADHD and DBD. Boys with the 
short allele of 5-HTT LPR or MAO-A in combination with high MAO-B activity in 
platelets above the median, scored higher on ADHD related traits. 
 
Within the group with high MAO-B activity, boys carrying the 5-HTT LPR_s allele 
scored significantly higher on all ADHD-related phenotypes tested than subjects 
carrying the 5-HTT LPR_l allele (ADHD_comb (p<0.001), ODD (p=0.007), CD 
(p=0.004) and DBD (p<0.001). No similar effect was found in the female subjects. 
Among boys carrying the MAO-A VNTR_s allele, the group with high platelet MAO-
B activity scored higher on the ADHD combined type (p=0.002). In the group with 
high MAO-B activity, boys carrying the 5-HTT LPR_s allele scored significantly 
higher on all ADHD-related phenotypes tested than subjects carrying the 5-HTT LPR-l 
allele ADHD combined (p<0.001), ODD (p=0.007), CD (p=0.004) and DBD 
(p<0.001). No similar effect was found in the female subjects. Among boys carrying 
the MAO-A VNTR-s allele, the group with high platelet MAO-B activity scored higher 
on the ADHD combined type (p=0.002) (Fig. 3). 
 
 
 
 
Fig.  3 ADHD symptoms and association to short 5-HTT LPR or short MAO-A VNTR 
genotype in combination with high platelet MAO-B activity 
a) Individuals with short 5-HTT LPR or short MAO-A VNTR genotype scored higher on 
ADHD symptoms if exhibiting high platelet MAO-B activity. **p<0.01, ***p<0.001 
b) Individuals with long 5-HTT LPR or long MAO-A VNTR genotype exhibited no 
differences in ADHD scores associated to platelet MAO-B activity. NS=Not significant 
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6.3 PAPER III 
The comorbidity between the subthreshold diagnoses for ADHD_comb and DBD was 
as follows; the study group consisted of 312 participants; 252 individuals did not fulfil 
the criteria for any of the diagnoses, 10 had subthreshold ADHD_comb alone, 31 had 
subthreshold DBD alone and 19 individuals fulfilled the criteria for both subthreshold 
ADHD_comb and subthreshold DBD. 
 
6.3.1  K-SADS-PL screening interview  
There were several psychiatric symptoms from the K-SADS-PL interview that are 
frequently reported and some of which differed significantly between genders (Fig.4).  
 
Commonly reported symptoms from the K-SADS-PL are as follows for depressive 
disorder in the item ”Irritability” (boys 13.3%, girls 18.6%), for mania; in the items 
“Increased goal directed activity” (boys 8.2%, girls 13.6%) and “Racing thoughts” 
(boys 7.4%, girls 13.0%) as well as separation anxiety disorder symptom in the “Fears 
harm befalling attachment figure”, which was commonly reported by girls (boys 
11.1%, girls 17.0%). In the social phobia avoidant disorder, the items reported were, 
“Shrinks from contact” (boys 25.2%, girls 24.9%), “Fears social situations” (boys 
28.2%, girls 32.8%) and “Avoidance” (boys 21.5%, girls 25.4%). Among the 
symptoms of ODD; “Loses temper” was one of the most commonly reported items 
(boys 19.3%, girls 22.6%). With regard to PTSD among the most frequently mentioned 
items was; “Ever confronted with traumatic news” (boys 31.9%, girls 41.8%). 
Cigarette/tobacco use, regular use of alcohol and substance use did not differ 
significantly between the genders, as the items evoked the following responses; ever 
tried smoking (boys 51.9%, girls 54.5%), regular use of alcohol (boys 18.5%, girls 
13.0%) and ever tried cannabis (boys 9.6%, girls 4.5%). 
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Fig. 4 Statistically significantly gender differences for items in the K-SADS-PL. 
 
 
 
6.3.2 Subthreshold diagnoses of ADHD/DBD and coexisting psychiatric 
symptoms 
Subthreshold diagnoses of ADHD and DBD coexisted with the K-SADS-PL screening 
questions on depression, mania, panic attacks, phobias, anorexia nervosa, motor tics 
and posttraumatic stress disorder (PTSD) in girls. In boys, these subthreshold diagnoses 
coexisted with symptoms of depression and PTSD. 
 
Statistically significantly results with regard to the K-SADS-PL screening questions 
and subthreshold diagnoses of ADHD and DBD for boys and girls (total population) 
are presented in Fig. 5 and 6. 
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Fig. 5 The items with a significant OR in relation to subthreshold diagnoses of 
ADHD_comb and coexisting problems in the total population based on the K-SADS-
PL screening interview 
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Fig. 6 The items with significant OR in relation to subthreshold diagnoses of DBD and 
coexisting problems for the total population based on the K-SADS-PL screening 
interview 
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6.3.3 Subthreshold diagnoses of ADHD/DBD and high consumption of 
smoking, alcohol and use of various drugs 
In both boys and girls, smoking and high consumption of alcohol contributed to a high 
OR with regard to ADHD and DBD. 
 
The in-depth interview in the K-SADS-PL for alcohol abuse in the item; “Quantity” 
was related to both ADHD_comb and DBD in boys, while in girls it was associated 
with DBD. In boys in the items; ”Frequency drinking” was related to DBD and 
“Concern from others about drinking” was linked to ADHD_comb. In both boys and 
girls, the item smoking more than two cigarettes/day was related to ADHD_comb and 
DBD .For boys and girls together the results are presented in Table 8. 
 
 
Table 8. The relationships between the subthreshold diagnoses of ADHD_comb/DBD 
based on the in-depth interview in the K-SADS-PL in relation to symptoms of alcohol 
and smoking in the total population (n=312) 
 
*p<0.05 ,** p<0.01, ***p<0,001 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnostic class and items ADHD_comb 
OR (95%CI) 
DBD 
OR (95%CI) 
Alcohol Abuse   
Quantity 4.25** (1.66–10.90) 10.73*** (4.90-23.50) 
Frequency drinking 2.55 (0.23-28.00) 14.59* (1.45-146.17) 
Concern from Others about Drinking 2.20 (0.55-8.85) 13.62*** (3.82-48.61) 
Smoking   
> 2 cigarettes/day 7.70*** (3.52-16.84) 11.77*** (5.11-21.13) 
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6.4 PAPER IV 
In this paper MAO-B activity in platelets and 5-HTT LPR polymorphism and 
association with various psychiatric symptoms based on the K-SADS-PL screening 
questionnaire was studied. 
 
6.4.1 MAO-B and 5-HTT LPR associated to psychiatric symptoms 
Low MAO-B activity in platelets was associated with symptoms of depressive disorder 
in the item “Irritability and anger”, symptoms of separation anxiety disorder in the item 
“Fears harm befalling attachment figure” and symptoms of ODD in the item “Disobeys 
rules a lot” (Table 9). 
 
Homozygosity of the long allele in 5-HTT was related to symptom  of depressive 
disorder in the items ”Irritability and anger” and “Anhedoni lack of interest”, symptoms 
of separation anxiety disorder in the item “Fears being alone at home” and substance 
abuse in the item “Ever tried cannabis” (Table 9).  
 
Heterozygosity for 5-HTT genotype was associated with symptom of ADHD in the 
item “Impulsiveness” (Table 9).  
 
Homozygote of the short 5-HTT LPR allele did not show any statistically significance 
in relation to any items in the K-SADS-PL questionnaire alone (Table 9). 
 
The percentage of individuals reporting significant items (symptoms) related to the K-
SADS-PL and 5-HTT LPR genotype compared to those reporting the items without the 
specific phenotype are presented in Table 10. 
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Table 9. MAO-B activity in platelets and 5-HTT LPR genotype in relation to psychiatric symptoms according to K-SADS-PL questionnaire 
 
1MAO-B activity in platelets as a continuous variable  
 2The specific 5-HTT polymorphism compared with the sample without the specific 5-HTT polymorphism 
*p<0.05, **p<0.01, ***p<0.001 
 
Diagnostic class and item MAO-B1 
β-coeff (95% CI) 
5-HTT-ll2 
β-coeff (95% CI) 
5-HTT-ls2 
β-coeff (95% CI) 
5-HTT-ss2 
β-coeff (95% CI) 
Depressive Disorders     
Depressed mood     
Irritability and anger -0.17 (-0.30; –0.04)* 0.92 (0.22;1.63)*   
Anhedoni, lack of interest  1.51 (0.04; 2.98)*   
Separation anxiety disorder     
Fears harm befalling attachment figure -0.09 (-0.18; -.001)*    
Fears being alone at home  1.51 (0.08; 2.94)*   
Obsessive Compulsive Disorder     
Obsession     
Attention Deficit Hyperactivity Disorder     
Impulsiveness   0.96 (0.34;1.59)**  
Oppositional Defiant Disorder     
Disobeys rules a lot -0.14 (-0.28; -0.001)*    
Tic Disorder     
Phonic tics     
Substance abuse     
Ever tried Cannabis  1.03 (0.01; 2.05)*   
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Table 10. Percentage of the individuals having the items according to K-SADS-PL 
questionnaires and 5-HTT LPR genotype 
 
1The specific 5-HTT polymorphism compared with the sample without the specific 5-HTT 
polymorphism 
* Each row shows the percentage having the item (symptom) according to K-SADS-PL. 
Individuals with the specific phenotype compared with the sample without the specific 
phenotype. The items are presented with the statistically significant items according to Table 9 
 
 
6.4.2  The interaction between MAO-B and 5-HTT LPR associated to 
psychiatric symptoms 
The interaction between 5-HTT LPR genotype and MAO-B activity in platelets was 
analysed. Interaction between homozygosity for the long 5-HTT allele and MAO-B 
activity in platelets was associated with symptoms of separation anxiety disorder in the 
item “Fear of being alone home”. Interaction between heterozygosity for 5-HTT and 
MAO-B activity in platelets was associated with symptoms of separation anxiety 
disorder in the items “Fears harm befalling attachment figure”, with symptoms of CD 
in the item ”Nonaggressive stealing” and with symptoms of tic disorder in the item 
“Phonic tics”. Interaction between homozygosity for the short 5-HTT allele and MAO-
B activity in platelets was associated with symptoms of depressive disorder in the items 
“Depressed mood” and “Irritability and anger”, with symptoms of separation anxiety 
disorder in the items “Fears harm befalling attachment figure”, with symptoms of OCD 
in the item “Obsession” and with symptoms of tic disorder in the item “Phonic tics“ 
(Table 11). 
 
Diagnostic class and item 5-HTT-ll1 5-HTT-ls1 5-HTT-ss1 
 No  Yes No Yes No Yes 
Depressive Disorders       
Irritability and anger 11.1* 23,2     
Anhedoni, lack of interest 2.6 9.8     
Separation anxiety disorder       
Fears being alone at home 2.6 9.8     
Attention Deficit Hyperactivity Disorder       
Impulsiveness   30.6 53.5   
Substance abuse       
Ever tried Cannabis 5.1 13.4   
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Table 11. Interactions between MAO-B activity in platelets and 5-HTT LPR genotype based on the K-SADS-PL  
questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 The interaction between MAO-B activity in platelets as a continuous variable and the specific 5-HTT  
polymorphism compared with the sample without the specific 5-HTT polymorphism. 
 *p<0.05, **p<0.01, ***p<0.001 
Diagnostic class and item MAO-B/5-HTT-ll1 
β-coeff (95% CI) 
MAO-B/5-HTT-ls1 
β-coeff (95% CI) 
MAO-B/5-HTT-ss1 
β-coeff (95% CI) 
Depressive Disorders    
Depressed mood   8.79 (8.01; 9.57)*** 
Anhedoni, lack of interest   8.54 (7.77; 9.31)*** 
Separation anxiety disorder    
Fears harm befalling attachment  figure  -0.24 (-0.47; -0.01)* -0.09(-0.18; -.001)* 
Fears being alone at home -0.41 (-0.79; -0.02)*   
Obsessive Compulsive Disorder    
Obsession   -0.50 (-0.75; -0.25)*** 
Attention Deficit Hyperactivity Disorder    
Impulsiveness    
Oppositional Defiant Disorder    
Disobeys rules a lot    
Conduct Disorder    
Nonaggressive stealing  -0.69 (-1.36; -0.27)*  
Tic Disorder    
Phonic tics  0.26 (0.01: 0.52)* -0.28 (-0.56; -0.01)* 
Substance abuse    
Ever tried Cannabis    
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In order to further show the combination between MAO-B activity in platelets and 5-
HTT LPR genotype and the relation with specific symptom the sample were divided 
into four groups, according to high/low level of MAO-B and the specific 5-HTT 
polymorphism yes/no. The results for the group with low MAO-B activity in platelets 
and 5-HTT LPR-ll+ls for the item “Iirritability and anger” (Fig. 7). 
 
 
Fig. 7 The item irritability and anger  
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7 DISCUSSION 
 
The main findings of this population-based study in adolescents are that ADHD and 
DBD phenotypes were associated with MAO-B activity in platelets as well as with the 
5-HTT LPR and with the MAO-A VNTR genotypes. The ADHD and DBD phenotypes 
were based on criteria in the DSM-IV-TR. A number of reports have found that 
deviant behaviour, correlates with these candidate genes and MAO-B activity in 
platelets.  
 
In Paper I we investigated the association between phenotypes and candidate 
genes/MAO-B activity in platelets separately. The findings were that MAO-B activity 
in platelets as well as the 5-HTT LPR and the MAO-A genotypes were associated with 
DBD.  
 
In Paper II we continued to study how these phenotypes were associated with the 
combination of candidate genes and MAO-B activity in platelets.  The combination of 
the 5-HTT LPR and MAO VNTR genotypes with low and high platelet MAO-B 
activity were analysed. A stronger correlation with ADHD-like problems evolved when 
these markers were combined. 
 
In Paper III we studied the complexity of these phenotypes in association with various 
coexisting psychiatric problems. The results revealed that subthreshold diagnosis of 
ADHD_comb and DBD coexist with several psychiatric problems such as depression, 
mania, panic attacks, phobias, anorexia nervosa, motor tics, PTSD as well as with 
smoking and high alcohol consumption. 
 
Paper IV we further explored the results in Papers I-III and studied how separate 
psychiatric symptoms based on the K-SADS-PL interview were associated with MAO-
B activity in platelets and the 5-HTT LPR genotype. These studies revealed that 
psychiatric symptoms were associated with the 5-HTT LPR genotype and with platelet 
MAO-B activity separately and in interaction.  
 
A discussion of the results from Papers I-IV will now continue by highlighting a few 
key questions. 
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Are ADHD and DBD phenotypes associated with MAO-B activity in platelets and 
polymorphism in the MAO-A VNTR and 5-HTT LPR genotypes separately and in 
combination? 
 
Paper I: The main finding of this study was the association between low platelet 
MAO-B activity and high scores for symptoms for ODD and DBD in girls. 
Hemizygosity of the short MAO-A VNTR allele was associated with DBD symptoms 
in boys. In both girls and boys the heterozygote 5-HTT LPR genotype was associated 
with CD, while in boys it was also associated with DBD.  
 
MAO-B is present in platelets and its activity has been suggested to be a marker for the 
monoamine capacity of the brain. Low platelet MAO-B activity correlates with deviant 
behaviour and has also been linked to ADHD as well as temperament (Shekim, Bylund 
et al. 1986; Klinteberg, Levander et al. 1987; Furmark, Tillfors et al. 2004; Oreland 
2004; Oreland, Hallman et al. 2004; Nilsson, Wargelius et al. 2008; Gau, Ni et al. 
2010). The hypothesis that low platelet MAO-B activity is associated with high scores 
of ADHD and DBD phenotype scores was only verified for ODD as well as DBD 
symptoms in girls. Anti-social behaviours are more believed to be under-diagnosed in 
girls (Newcorn, Halperin et al. 2001; Biederman, Monuteaux et al. 2006). It is therefore 
possible that the girls exhibiting symptoms in the present study had more severe 
symptoms or more deviant personalities than boys reporting the same behaviour. This 
explanation is in agreement with Cederblad et al (Cederblad, Oreland et al. 1992). 
 
The MAO-A VNTR has been linked to personality traits such as impulse control and 
antagonistic behaviour (Manuck, Flory et al. 2000; Meyer-Lindenberg, Buckholtz et al. 
2006). The hypothesis was that MAO-A genotype in boys would be associated with 
subtypes of ADHD in which aggressive and impulsive behaviours are especially 
prominent. The findings are in line with those of Lawson et al. (Lawson, Turic et al. 
2003) who found a correlation between the short MAO-A allele and CD in boys with 
ADHD. There are other studies reporting an association with ADHD related behaviours 
and the long MAO-A allele (Kim-Cohen, Caspi et al. 2006), as well as studies in which 
no association were found (Faraone, Perlis et al. 2005). 
 
In both boys and girls, the 5-HTT LPR heterozygosity was associated with high scores 
for the DBD phenotype. Such molecular heterosis at the 5-HTT gene has been observed 
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in some previous studies, where heterozygote subjects were found to have greater 
influences on the binding capacity of the 5-HTT as well as on behavioural traits, e.g. 
social drinking and depression, than homozygotes (Comings and MacMurray 2000). 
Furthermore, in a study, by van Dick et al. (van Dyck, Malison et al. 2004) central 5-
HTT availability was found to be lowest in heterozygous subjects. Heterosis has also 
been reported for other monoamine receptor genes (Comings and MacMurray 2000). In 
a recent article, by Sonuga-Barke et al. (Sonuga-Barke, Kumsta et al. 2011) arrived at 
the same result as in Paper I. These authors discussed our findings and explained how 
the following effects could be involved: 1) an inverted U-shaped response curve in 
which either too little or too much gene expression is harmful; 2) an independent third 
factor causing a hidden stratification of the sample so that the two homozygote 
genotypes (s/s and l/l) are independently associated with the highest phenotype score 
relative to the heterozygote (e.g., s/l); and 3) greater fitness in heterozygotes, because 
they show a broader range of gene expression than both homozygotes (for a review see 
(Comings and MacMurray 2000). The findings from Sonuga-Barke et al (Sonuga-
Barke, Kumsta et al. 2011) were that the 5-HTT LPR genotype was associated with 
delay aversion, where s-allele carriers were more delay averse than non carriers in 
individuals with ADHD. This confirmed the observation of a somewhat of a different 
pattern of results for the two groups and an unexpected heterosis effect in the ADHD 
group (the s/l group being the most delay averse). This raises the possibility that the 5-
HTT LPR genotype influences impulsive behaviour. With regard to the 5-HTT LPR 
polymorphism, there are also conflicting results as some studies found associations 
between an ADHD phenotype and both the long and the short allele while others 
observed no such association (Faraone and Khan 2006; Thapar, Langley et al. 2006). 
 
The gender ratio for ADHD and DBD is somewhat lower than previously reported. One 
explanation could be that the sample consisted of adolescents with mean age of 16 
years, who are between childhood and adulthood, whereas in other studies the subjects 
were usually either children or adults. Meta-analyses of childhood ADHD have shown 
a male:female ratio of 3:1 in non referred populations (Gaub and Carlson 1997). The 
gender differences in this study were of 1.6:1 for subthreshold diagnoses of ADHD 
combined type. Studies of adult ADHD have shown ratios of 1.6:1 (Kessler, Adler et 
al. 2006) and even 1:1 (Faraone and Biederman 2005). One possible explanation of the 
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gender difference might be an effect of sex hormones on the activity of several genes 
within the monoamine field (Doyle, Biederman et al. 2003).  
 
Compounds in cigarette smoke exert an inhibitory effect on MAO activity, but are only 
reported to be significant in quantities exceeding 300 cigarettes per month (Snell, Glanz 
et al. 2002). In the present study smoking was controlled for and to further investigate 
its potential effects of smoking on the results, by using the information from the K-
SADS-PL to identify the subjects who had smoked more than two cigarettes per day in 
combination with the group who had smoked during a 24 hours prior the blood sample. 
 
Paper II: A more accurate picture emerged when the genetic markers (the 5-HTT LPR 
and MAO-A VNTR genotypes with platelet MAO-B activity) were combined, 
compared with the cases to when these markers were analysed separately. Among boys 
(not girls) carrying either the short 5-HTT LPR or the short MAO-A VNTR allele, 
subjects with high platelet MAO-B activity scored higher on the ADHD-related 
phenotypes. 
 
Most reports indicate that low MAO-B activity is associated with deviant behaviour 
such as sensation seeking and type II alcoholism (Oreland 2004; Oreland, Hallman et 
al. 2004), but there are some reports suggesting different dimensions of deviant 
behaviour  are associated with extreme levels of platelet MAO-B activity (high or low) 
(Klinteberg, Levander et al. 1987; Stoff, Friedman et al. 1989). High platelet MAO-B 
activity may reflect anxiety-related traits as opposed to impulsive traits which are 
linked to low platelet MAO-B activity. Comorbidity with anxiety is prevalent in ADHD 
(Schatz and Rostain 2006; Jarrett and Ollendick 2008), which agrees with the present 
results of high platelet MAO-B activity in individuals with high ADHD scores, thus it 
may be that affected individuals have coexisting anxiety. MAO-B knock-out mice have 
been found to exhibit behavioural disinhibition and a reduction of anxiety-like 
behaviours (Bortolato, Godar et al. 2009). 
 
Are subthreshold diagnoses of ADHD and DBD related to other symptoms of 
child and adolescent psychiatric disorders?  
 
Paper III: Subthreshold diagnoses of ADHD and DBD were found to coexist with 
various psychiatric symptoms based on the K-SADS-PL interview; depression, mania, 
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panic attacks, phobias, anorexia nervosa, motor tics and PTSD in girls while in boys, 
these subthreshold diagnoses were found to coexist with symptoms of depression and 
PTSD.  
 
Psychiatric diagnoses are classified by means of structured interviews based on 
symptoms from categorical diagnosis. Another way to describe mental health is to use 
the summary score of psychiatric symptoms that is a dimensional scale of symptoms. 
ADHD and DBD phenotypes are complex and there is an increased tendency for 
researchers to refine the phenotype in the secondary analysis (Thapar, Langley et al. 
2006). In the study, the phenotypes were determined by subthreshold diagnoses of 
ADHD_comb and DBD (ODD or CD). Subthreshold diagnoses of ADHD and DBD in 
adolescents are important, as these conditions are often accompanied by coexisting 
psychiatric/ psychological problems. In a large study of adolescents and young adults, 
more than half (52.5%) of the participants had experienced a subthreshold state at some 
point in their life and 40% of those with at least one subthreshold condition had one or 
several additional conditions, while over 36.4% of the participants with a subthreshold 
condition also had a comorbid full syndrome diagnosis. Thus, subthreshold conditions 
are precursors of full syndrome disorders (Lewinsohn, Shankman et al. 2004; 
Shankman, Lewinsohn et al. 2009). A series of papers (Faraone, Biederman et al. 2006; 
Faraone, Wilens et al. 2007; Faraone, Kunwar et al. 2009) found that late-onset and full 
ADHD subjects had similar psychiatric comorbidity patterns; neuropsychological 
impairment, substance use disorders and familial transmission. Subthreshold ADHD 
was milder than late-onset adult ADHD and might be a milder a less severe condition. 
In adults, subthreshold ADHD cases showed deviations in novelty seeking and self-
directiveness (Faraone, Perlis et al. 2005). 
 
Thus the findings were that, mild and non-clinical symptoms of ADHD and DBD are 
not isolated conditions, but part of other psychiatric/psychological problems. These 
findings are in agreement with several clinical studies showing that ADHD and DBD 
coexist with other psychiatric symptoms and impairments and that comorbidity is a 
clinical feature of both childhood and adult ADHD (Biederman, Petty et al. 2010). 
ADHD frequently coexists with DBD in the same way as functional impairment 
coexists with anxiety and/or depression. Children suffering from both CD and ADHD 
exhibit greater ADHD and CD symptom severity, a stronger association with 
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neurobiological correlates and poorer outcome than those with  either disorder 
separately (Thapar, Langley et al. 2006; Bussing, Mason et al. 2010; Mordre, Groholt et 
al. 2011). Comorbidity and coexisting psychiatric symptoms and impairments were 
found in population-based studies of children with ADHD (Scahill and Schwab-Stone 
2000), ODD and CD (Kutcher, Aman et al. 2004). Population-based studies of adults 
demonstrated that both adult women and men with ADHD are at increased risk of other 
psychiatric disorders (Friedrichs, Igl et al. 2010) as well as the fact DBD is associated 
with comorbidity with other psychiatric conditions (Reef, Diamantopoulou et al. 2010).  
 
There were gender differences in that girls exhibited more symptoms of depression, 
mania, panic anxiety, social phobia, agoraphobia and specific phobia, anorexia nervosa 
and motor tics in association with subthreshold diagnoses of ADHD and DBD. These 
findings are similar to the results of Kopp et al. (Kopp, Kelly et al. 2010), who revealed 
that girls referred to a psychiatric outpatient clinic with social and/or attention deficits 
often had serious psychiatric comorbidities and low global levels of functioning. Boys 
with subthreshold diagnoses of ADHD and DBD reported more symptoms of PTSD. A 
possible explanation may be that novelty seeking has been reported to be associated 
with DBD and other reports of overlapping of symptoms between PTSD and ADHD 
(Schmeck and Poustka 2001; Daud and Rydelius 2009). 
 
Subthreshold diagnoses appear to be important from both a clinical and research, 
perspective, as many with such diagnoses exhibit a great deal of comorbidity with other 
psychological and psychiatric symptoms. However, studying subthreshold diagnoses 
may be a difficult way to get a pure phenotype. In the present study comorbidity 
between these diagnoses was as follows 10 had subthreshold ADHD_comb, 31 had 
subthreshold DBD while 19 individuals fulfilled the criteria for both subthreshold 
ADHD_comb and subthreshold DBD. This pattern may be similar to a clinical 
population as developmental and psychiatric diagnoses often coexist with other 
problems and are not isolated conditions. One difficulty is that subthreshold diagnoses 
criteria differ from late-onset or full syndrome criteria and that there is a general lack of 
consensus. Furthermore individuals with subthreshold diagnoses may need a similar 
degree of help and treatment as those with the full syndrome. 
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Are high scores of ADHD and DBD risk behaviour related to smoking, alcohol 
consumption and use of various drugs? 
 
Paper III: We were in this study able to show that the section of the in-depth K-
SADS-PL interview that dealt with smoking and high alcohol consumption was related 
to subthreshold diagnoses of ADHD and DBD in both boys and girls. This result is 
similar to Faraone et al. (Faraone, Wilens et al. 2007), who found that full syndrome 
and late onset ADHD groups had identical cigarette smoking and substance use 
profiles. Heffner et al. (Heffner, Johnson et al. 2010) demonstrated that childhood 
symptoms of inattention and hyperactivity/impulsivity are related to cigarette smoking 
and nicotine dependence among alcohol-dependent individuals at levels below the 
ADHD diagnostic threshold. A recent study by Baker et al. (Baker, Prevatt et al. 2011) 
found that students with difficulties in self-regulation and with ADHD are at increased 
risk for problematic alcohol intake and subsequent risk for alcohol-use disorders when 
compared their peers. Responses in the section of the K-SADS-PL interview that dealt 
with use of various drugs revealed that 21/312 of the adolescents had tried cannabis but 
only one parent had knowledge about this. The results highlight the importance of a 
broad clinical assessment of adolescents with preliminary diagnoses of ADHD and 
DBD, including questions about alcohol consumption, smoking and the use of various 
drugs. 
 
What is the association between individual psychiatric symptoms and behavioural 
problems based on the K-SADS-PL interview and polymorphism in the 5-HTT 
LPR genotype and MAO-B activity in platelets? 
 
Paper IV: This study showed that several psychiatric symptoms in the K-SADS-PL 
were associated with the 5-HTT genotype and with platelet MAO-B activity. When the 
two markers were combined another picture emerged with regard to several of the 
symptoms. In line with previous findings on ADHD, when two markers were combined 
a more conclusive picture of several symptom emerged (Wargelius, Malmberg et al. 
2011). 
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It should be noted that none of the symptoms tested were associated with the short 5-
HTT allele alone but when the short 5-HTT allele was seen in combination with MAO-
B activity in platelets another picture of symptoms of depressive disorder emerged.  
 
Low MAO-B activity in platelets was associated with the items “Irritability and anger”, 
“Fears harm befalling attachment figure” and “Disobeys rules a lot”. In Malmberg et al. 
(Malmberg, Wargelius et al. 2008) found that symptoms of ODD and DBD were 
associated with low MAO-B platelet activity in girls. Nilsson et al. (Nilsson, Wargelius 
et al. 2008) demonstrated that girls with low platelet MAO-B activity had an increased 
risk of alcohol-related behaviour in an unfavourable environment. In summary, low 
MAO-B platelet activity seems to indicate vulnerability to several types of behavioural 
problem.  
 
Homozygosity of the long allele in 5-HTT was related to the items “Irritability and 
anger”, “Anhedoni, lack of interest”, “Fears being alone at home”, and “Ever tried 
cannabis”. Heterozygosity of the 5-HTT gene was associated with the item 
“Impulsiveness”. Although we used a non-clinical sample of adolescents, our findings 
are in line with previous studies of adult patients as well as a large population based 
study showing that variations in the serotonin transporter are considered to be an 
important factor in anxiety-depression related personality traits as they are linked to 
violent behaviour and aggression (Collier, Stober et al. 1996; Merikangas, He et al. 
2010). 
 
7.1 METHODOLOGICAL CONSIDERATION 
Some limitations should be mentioned. First of all the study population was not a 
clinical one and individual symptoms that were studied were both clinical and 
subclinical, making it difficult to know if the findings are representative of specific 
psychiatric diagnoses. The sample is fairly small and there is a risk that the results 
could lead to false positives or false negatives, hence, the positive associations reported 
here need to be validated in larger samples. Another limitation in Paper IV is that we 
did not separately analyse the results for boys and girls because of the small sample. 
 
The generalizability of this population-based study may be limited because apart from 
the small sample size, the subjects were twins that were treated as individuals and thus 
twin methodology was not used. However, studies of twins have shown that twins’ 
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behavioural problems are representative of a general population. Gjone et al. (Gjone 
and Novik 1995) compared behavioural problems in a general and a twin population 
and found that the level of attention problems and externalizing behaviour was similar 
and that the likelihood of developing a disorder is influenced by similar factors in twins 
and singletons. Thus the generalizability in this study does not seem to differ from that 
of other studies. 
 
When the interviews were conducted the first Swedish version of K-SADS-PL was 
used, which does not include a screening question about autism spectrum disorder 
(ASD). White et al. (White, Ollendick et al. 2011) examined the prevalence of ASD in 
students at a university and depending on method used, found that between 0.7 and 1.9 
per cent fulfilled the criteria for High Functioning ASD. It is difficult to envision that 
out of 312 individuals so many suffered from ASD. However, it may have been the 
case that some of them had coexisting problem. One girl had already been diagnosed 
with Asperger’s syndrome at the time of the interview. 
 
However, the strength of the study is that the interviews constituted a clinical 
assessment where the answers from both adolescents and parents were evaluated by a 
trained physician, which favourable contrast with studies that rely on self-reported 
questionnaires. 
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8 CONCLUSIONS AND CLINICAL IMPLICATIONS 
 
Measurements of MAO-B activity in platelets as well as the 5-HTT LPR and the MAO-
A VNTR genotypes revealed that individuals with these genotypes alone and in 
combination are more likely to have high ADHD and DBD score. Several of 
psychiatric symptoms based on the K-SADS-PL interview were associated with the 5-
HTT LPR genotypes and with platelet MAO-B activity alone and in combination. 
 
These results suggest that the serotonin system is involved in the etiology of ADHD, 
DBD and other psychiatric symptoms, thus requiring further investigation. The 
heterosis effect found in ADHD and CD highlights the importance of conducting 
separate analyses of all genotype groups, rather than pooling alleles together as is 
frequently the case in association studies (Comings and MacMurray 2000; Malmberg, 
Wargelius et al. 2008; Sonuga-Barke, Kumsta et al. 2011). More and larger studies are 
needed to validate these results. 
 
The complexity of the ADHD and DBD phenotypes was shown by the association with 
several psychiatric and behavioural problems. Subthreshold diagnoses of ADHD and 
DBD were associated with positive findings with regarding to symptoms from the K-
SADS-PL screening interview related to the following psychiatric problem areas: 
depression, mania, psychosis, anxiety, eating disorders and trauma. However, there 
were more symptoms of anxiety and trauma related to DBD compared to ADHD. In 
both boys and girls, smoking and high alcohol consumption where seen as to risk 
behaviours in association with subthreshold diagnoses. The gender differences in the 
symptoms found in Paper III are similar to those reported by Laukkanen (Laukkanen, 
Hintikka et al. 2010), which suggests that the assessment of symptoms based on the K-
SADS-PL is valid in the light of Swedish and international studies. This emphasizes 
that ADHD and DBD constitute a significant risk to mental health. A broad clinical 
assessment is therefore necessary for adolescents with a preliminary diagnosis of 
ADHD and DBD to detect other psychiatric/psychological problems and provide target 
treatment as well as to identify individuals with risk behaviour related to alcohol, 
smoking and use of various drugs, for which the K-SADS-PL is a good assessment 
instrument. 
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Although this is a small sample, the present study indicates that the serotonergic system 
is involved in the etiology of ADHD and DBD as well as other psychiatric symptoms. 
Pharmacological and genetic studies have demonstrated the importance of the 
dopaminergic, serotonergic and noradrenergic systems in the pathogenesis of ADHD 
and DBD. Thus knowledge of how various symptoms can be explained by different 
candidate genes and neurotransmitter systems enhance the opportunity to identify the 
most appropriate pharmacological treatment. However, larger samples are needed as 
well as more pharmacological studies. 
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